The AI4LUNGS large multi-disciplinary consortium will develop and validate innovations jointly built-in partnership with 10 countries including Europe’s highly acclaimed academic, research and medical centers, technology providers, policymakers, legal, regulation, ethics as well as exploitation and innovation experts. 

 

The consortium consists of 18 partners from eight different EU Member States (Portugal, Germany, Greece, Netherlands, Spain, Cyprus, Belgium,Italy) and two Associated Countries (Israel, Norway).